Table 3. Univariate analysis of factors... | American Society of Hematology

Table 3.

Univariate analysis of factors influencing 2-year actuarial relapse risk, overall survival (OS), and event-free survival (EFS)

	Relapse, %	P	OS, %	P	EFS, %	P
Age		.047		.066		.005
46 y and younger	4.8		84.1		77.6
Older than 46 y	37.8		53.4		38.7
Donor		.72		.39		.53
Related	19.5		65.9		57.0
Unrelated	16.7		85.7		68.6
Prior autograft		.53		.013		.01
Yes	11.1*		42.8†		42.9‡
No	0.0*		74.8†		63.9‡
Risk group		.30		.79		.42
Low	11.1		76.9		75.2
Intermediate	37.0		59.2		51.8
High	7.1		65.6		47.9
GVHD		.059		.26		.35
Yes	0.0		71.5		68.0
No	29.4		67.8		55.6
Diagnostic group		.014		.066		.018
Low-grade disease§	10.0		74.3		69.0
MCL/high-grade NHL	67.9		45.4		16.8

	Relapse, %	P	OS, %	P	EFS, %	P
Age		.047		.066		.005
46 y and younger	4.8		84.1		77.6
Older than 46 y	37.8		53.4		38.7
Donor		.72		.39		.53
Related	19.5		65.9		57.0
Unrelated	16.7		85.7		68.6
Prior autograft		.53		.013		.01
Yes	11.1*		42.8†		42.9‡
No	0.0*		74.8†		63.9‡
Risk group		.30		.79		.42
Low	11.1		76.9		75.2
Intermediate	37.0		59.2		51.8
High	7.1		65.6		47.9
GVHD		.059		.26		.35
Yes	0.0		71.5		68.0
No	29.4		67.8		55.6
Diagnostic group		.014		.066		.018
Low-grade disease§	10.0		74.3		69.0
MCL/high-grade NHL	67.9		45.4		16.8

Populations presented: relapse, n = 43; OS, n = 65; and EFS, n = 65.

1-year actuarial relapse risk.

1-year actuarial OS.

1-year actuarial EFS.

Low-grade lymphoproliferative diseases and HL.